(YBi)/sub 3/Fe/sub 2/O/sub 12/
Preparation, characterization, and cytotoxicity of CPT/Fe<sub>2</sub>O<sub>3</sub>-embedded PLGA ultrafine composite fibers: a synergistic approach to develop promising anticancer material
... CPT/Fe 2 O 3 -PLGA blend system was determined in buffer solution with respect to the morphological changes of the fibrous ...CPT/Fe 2 O 3 -PLGA was observed at 355 ...
12
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... a 12/12-hour light/dark ...a 2-week acclimatization for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si ...
16
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... onto Fe 3 O 4 @SiO 2 nanoparticles with high doxorubicin (DOX) loading (TfDMP), for dual targeting of cancer, by chemically coupling both Tf and DOX with dual-function magnetic nanoparticles ...
9
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... Pancreatic cancer cell line SW1990 supplied by the Depart- ment of Digestive Diseases of Changhai Hospital (Shanghai, People’s Republic of China) was cultured. In order to test the targeting ability of the A-MFS with ...
13
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... (PEI)-modified Fe 3 O 4 @SiO 2 , which allows high efficient loading of VEGF small hairpin (sh)RNA to form Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA nanocomposites for VEGF ...
13
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... ± 2 ° C, and 12-hour light/dark ...mg/kg Fe 3 O 4 -TiO 2 NPs or TiO 2 NPs, respectively) with six rats in each ...
15
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... Van/Fe 3 O 4 @SiO 2 @Ag microflower with enhanced antibacterial activity is experimentally and theoretically presented in this ...Van/Fe 3 O 4 @SiO 2 @Ag ...
18
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... encapsulate Fe 3 O 4 nanoparticles by an emulsion method ...the Fe 3 O 4 ...and Fe 3 O 4 -PLGA-PEG nanoparticles had no cytotoxicity and were ...loaded ...
16
Ultrasmall superparamagnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles: honey-based green and facile synthesis and in vitro viability assay
... the Fe 3 O 4 -NPs have spherical morphology and a uniform ...the Fe atoms as a covering material to create steric block, like the common stabilizers and ...
9
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... MNPs-Fe 3 O 4 (State Key Lab of Bioelectronics, Nanjing, China) were well distributed in RPMI 1640 medium containing 10% (v/v) heat-inactivated new-born calf serum (Sijiqing, Hangzhou, China) by ...
9
Inhibitory effect of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles coloaded with homoharringtonine on human leukemia cells in vivo and in vitro
... magnetic Fe 3 O 4 nanoparticles (MNP-Fe 3 O 4 ) to improve the therapeutic effect of HHT and investigated its biological ...HHT-MNP-Fe 3 O 4 showed a more ...
10
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... nm. The energy dispersive spectrometry results in Figure 1D and E show the atomic percentage of gadolinium and silicon in the core and the surface, respectively, indicating that the SiO 2 was successfully ...
11
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... the Fe 3 O 4 /Au nanocarrier, the ratio of HRP and Ab 2 is the most important factor in the response ...HRP/Ab 2 , and the maxi- mum response is achieved at a ratio of ...HRP/Ab ...
11
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... to Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing potentials ranging between − 80 and − 200 ...of ...
10
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... (MNP-Fe 3 O 4 ) and chemotherapeutic drugs on lymphoma ...MNP-Fe 3 O 4 ...MNP-Fe 3 O 4 with adriamycin or daunorubicin increased p53 protein levels and ...
6
Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... In the MRI examinations, a 7-T MRI system (Bruker, Ettlingen, Baden-Württemberg, Germany) was used for T 2 -weighted coronal images with an interval of 1 mm. An inhalation anesthesia system (Protech, Boerne, TX), ...
10
Effects of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> combinated with gambogic acid on apoptosis of SMMC-7721 cells
... of Fe 3 O 4 -MNP and GA on apoptosis induction in SMMC-7721 ...that Fe 3 O 4 -MNP at less than 20 μ g/mL concentration had no obvious influence on the multiplication of SMMC-7721 ...
6
Magnetic nanoparticle of Fe<sub>3</sub>O<sub>4</sub> and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells
... After treatment with drugs, total RNA was isolated using Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s protocol. One microgram of total RNA was used to generate cDNA ...
8
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
... A burden of peripheral arterial disease (PAD) prevalence has been observed over the last decade. Globally in 2010, about 202 million people were diagnosed with PAD. 1 PAD is now the third most common cause of death from ...
16
Reactivity of Au/La<sub>1 x</sub>Sr<sub>x</sub>Cr<sub>1 y</sub>Ni<sub>y</sub>O<sub>3 δ</sub> toward Oxidative Coupling of Methane for C<sub>2</sub> and C<sub>3</sub> Hydrocarbons Production
... Lacking of fossil fuels and the current global warming crisis drive the researchers to find new energy resources, which are of high efficiency and environmental friendly. Solid oxide fuel cell (SOFC) is known as an ...
12